TCWA
PRME icon

Turtle Creek Wealth Advisors’s Prime Medicine PRME Stock Holding History

Turtle Creek Wealth Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,000
Closed -$87K – 546
2026
Q1 		$87K Buy
+25,000
New +$95.2K 0.01% 419
2025
Q4 		– Sell
-25,000
Closed -$139K – 409
2025
Q3 		$139K Buy
+25,000
New +$102K 0.01% 361

Other funds holding PRME

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ACM
Alessandra Capital Management Torrance, California $141M AUM
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
MAM
Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IAMH
IvyRock Asset Management (HK) Sheung Wan, Hong Kong $177M AUM 10.49% 1-Year Est. Return

Turtle Creek Wealth Advisors's PRME Position: Q2 2026 in Review

Turtle Creek Wealth Advisors sold out of Prime Medicine (PRME) in Q2 2026, closing a stake of 25,000 shares — an estimated $87K sold.

Turtle Creek Wealth Advisors first reported a position in PRME in Q3 2025 and held it in 2 quarters. The position peaked at $139K in Q3 2025. 42 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Turtle Creek Wealth Advisors reported no remaining Prime Medicine position as of Q2 2026 after selling out during the quarter.
  • Turtle Creek Wealth Advisors sold 25,000 Prime Medicine shares in Q2 2026, an estimated $87K.
  • Turtle Creek Wealth Advisors first reported a position in Prime Medicine in Q3 2025 and held it in 2 quarters.
  • Turtle Creek Wealth Advisors's Prime Medicine position peaked at $139K in Q3 2025.
  • 42 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Turtle Creek Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.